ERBB2 and breast carcinoma: For example, when loading EVs with mRNA encoding proteins to activate prodrugs for human epidermal growth receptor 2-positive (HER2+) breast cancer, a separate group observed less mRNA in electroporated EVs than non-electroporated EVs, suggesting mRNA remained adhered to the surface of EVs and the failure of electroporation 116.